463
Participants
Start Date
July 31, 2009
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
INSULIN GLARGINE (HOE901)
LANTUS®: Solution for injection. 100U/mL in a prefilled pen (SoloStar®)
Insulin aspart
NovoMix® 30: Suspension for injection. 100U/mL in a prefilled pen (FlexPen®)
Insulin Glulisine
APIDRA®: Solution for injection. 100U/mL in a prefilled pen (SoloStar®)
Investigational Site Number 211, Maroubra
Investigational Site Number 213, Nowra
Investigational Site Number 204, Campbelltown
Investigational Site Number 205, Campbelltown
Investigational Site Number 202, Parkville
Investigational Site Number 212, Melbourne
Investigational Site Number 203, Heidelberg
Investigational Site Number 201, Caulfield
Investigational Site Number 206, Herston
Investigational Site Number 209, Milton
Investigational Site Number 207, Meadowbrook
Investigational Site Number 208, Southport
Investigational Site Number 214, Douglas
Investigational Site Number 210, Daw Park
Investigational Site Number 826-109, Aberdeen
Investigational Site Number 826-118, Ashton-under-Lyne
Investigational Site Number 826-157, Ayr
Investigational Site Number 826-149, Barnsley
Investigational Site Number 826-135, Bath
Investigational Site Number 826-124, Birmingham
Investigational Site Number 826-150, Birmingham
Investigational Site Number 826-106, Bournemouth
Investigational Site Number 826-136, Bradford
Investigational Site Number 826-130, Bristol
Investigational Site Number 826-114, Bury St Edmunds
Investigational Site Number 826-132, Carmarthen
Investigational Site Number 826-141, Cheadle
Investigational Site Number 826-147, Chester
Investigational Site Number 826-112, Chesterfield
Investigational Site Number 826-152, Chichester
Investigational Site Number 826-159, Cleveleys
Investigational Site Number 826-113, Colchester
Investigational Site Number 826-119, Cornwall
Investigational Site Number 826-162, Crawley
Investigational Site Number 826-145, Dafen
Investigational Site Number 826-165, Dumfries
Investigational Site Number 826-167, Durham
Investigational Site Number 826-173, East Kilbride
Investigational Site Number 826-105, Edinburgh
Investigational Site Number 826-115, Exeter
Investigational Site Number 826-160, Fleetwood
Investigational Site Number 826-107, Gateshead
Investigational Site Number 826-127, Glasgow
Investigational Site Number 826-174, Haddington
Investigational Site Number 826-164, Hereford
Investigational Site Number 826-126, High Wycombe
Investigational Site Number 826-102, Hull
Investigational Site Number 826-120, Ipswich
Investigational Site Number 826-163, Kirkcaldy
Investigational Site Number 826-161, Lancaster
Investigational Site Number 826-101, Liverpool
Investigational Site Number 826-108, Liverpool
Investigational Site Number 826-122, Livingston
Investigational Site Number 826-110, Llantrisant
Investigational Site Number 826-142, London
Investigational Site Number 826-123, London
Investigational Site Number 826-166, London
Investigational Site Number 826-137, Manchester
Investigational Site Number 826-156, Mortimer
Investigational Site Number 826-140, Newcastle upon Tyne
Investigational Site Number 826-138, Newport
Investigational Site Number 826-133, Nottingham
Investigational Site Number 826-121, Nuneaton
Investigational Site Number 826-129, Plymouth
Investigational Site Number 826-139, Saint Leonards-on-Sea
Investigational Site Number 826-116, Salford
Investigational Site Number 826-143, Scunthorpe
Investigational Site Number 826-104, Sheffield
Investigational Site Number 826-103, St Helens
Investigational Site Number 826-111, Stevenage
Investigational Site Number 826-131, Stirling
Investigational Site Number 826-146, Sunderland
Investigational Site Number 826-128, Westbury
Investigational Site Number 826-117, York
Lead Sponsor
Sanofi
INDUSTRY